These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32290844)

  • 1. Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice.
    Chen MY; Chai KM; Chiang CY; Wu CC; Yu GY; Liu SJ; Chen HW
    J Biomed Sci; 2020 Apr; 27(1):51. PubMed ID: 32290844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity.
    Chiang CY; Hsieh CH; Chen MY; Tsai JP; Liu HH; Liu SJ; Chong P; Leng CH; Chen HW
    Vaccine; 2014 Mar; 32(12):1346-53. PubMed ID: 24486311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
    Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
    Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement.
    Yen LC; Chen HW; Ho CL; Lin CC; Lin YL; Yang QW; Chiu KC; Lien SP; Lin RJ; Liao CL
    J Biomed Sci; 2023 Jun; 30(1):41. PubMed ID: 37316861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.
    Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L
    Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From
    Cibulski S; Varela APM; Teixeira TF; Cancela MP; Sesterheim P; Souza DO; Roehe PM; Silveira F
    Front Immunol; 2021; 12():632714. PubMed ID: 33746970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice.
    Yang M; Lai H; Sun H; Chen Q
    Sci Rep; 2017 Aug; 7(1):7679. PubMed ID: 28794424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody.
    Kim SI; Kim S; Shim JM; Lee HJ; Chang SY; Park S; Min JY; Park WB; Oh MD; Kim S; Chung J
    Biochem Biophys Res Commun; 2021 Mar; 545():33-39. PubMed ID: 33535104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis of Zika Virus-Specific Antibody Protection.
    Zhao H; Fernandez E; Dowd KA; Speer SD; Platt DJ; Gorman MJ; Govero J; Nelson CA; Pierson TC; Diamond MS; Fremont DH
    Cell; 2016 Aug; 166(4):1016-1027. PubMed ID: 27475895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
    Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
    Basu R; Zhai L; Contreras A; Tumban E
    Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice.
    Chiang CY; Liu SJ; Hsieh CH; Chen MY; Tsai JP; Liu HH; Chen IH; Chong P; Leng CH; Chen HW
    Vaccine; 2016 Feb; 34(8):1054-61. PubMed ID: 26776472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.
    Yang M; Dent M; Lai H; Sun H; Chen Q
    Vaccine; 2017 Jul; 35(33):4287-4294. PubMed ID: 28669618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zika virus like particles elicit protective antibodies in mice.
    Salvo MA; Kingstad-Bakke B; Salas-Quinchucua C; Camacho E; Osorio JE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006210. PubMed ID: 29401460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice.
    Liang H; Yang R; Liu Z; Li M; Liu H; Jin X
    PLoS One; 2018; 13(3):e0194860. PubMed ID: 29590178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
    Graham SD; Tu HA; McElvany BD; Graham NR; Grinyo A; Davidson E; Doranz BJ; Diehl SA; de Silva AM; Markmann AJ
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
    Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J
    Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.